Dreadful Christmas week sees big boys hit hard. The overall average of all covid vaccine stocks slumps to just 157%. The big boys (Novavax, Moderna and BioNTech) slip a total of 519 percentage points overall this week.
COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Sunday, 26 December 2021
Dreadful Christmas week - Big Boys hit hard. Near lowest ebb.....
Thursday, 23 December 2021
Flat Day - Immunity and Gritstone on the move. Generex falls out of bed
Almost exactly flat day with a gain of just 0.1% overall on average. There were 14 winners and 12 losers.
Immunity Bio was the strongest winner with a gain of just under 9%. Gritstone also made a move up of 6%.
On the other side, Arcturus continues to give back recent gains with a loss of 6%. Generex hit a new low with a loss of over 11% to close at just 6.2 cents per share.
Wednesday, 22 December 2021
Stocks slip 2.5% overall with Arcturus slipping 10%
Another tough day. The overall average was a loss of 2.5% with 21 stocks losing ground and only 5 gaining.
Arcturus, which has been strong lately, gave back 10%. IMV fell 8%. CureVac and OncoSec both fell 7%, Moderna, Alnylam and Ocugen fell 6%.
There was one stock which had a strong day: Immunity Bio, which picked up 6%.
Tuesday, 21 December 2021
Covid Stocks slip another 2%
Another day where Covid stocks ease back by another 2% (same amount as yesterday). Leaders on the downside were the big boys: Novavax and Dynavax down 7% and Moderna 6%. CureVac, Vir and Adaptive fell 5%.
Monday, 20 December 2021
Novavax and Dynavax lead the way down with 7% losses as stocks slip 2% overall
Covid stocks slid back to start the week with a loss of just under 2% on average.
Twenty-one lost ground with only five gaining.
Novavax and Dynavax lead the way down with 7% losses. Moderna lost 6% while CureVac, Vir and Adaptive all slipped 5%.
No stock picked up over 5%.
Friday, 17 December 2021
Rocket upwards - more than 5% on average. Immunity Bio, Gritstone, Novavax and Adaptive make a big move
Rocket up for Covid Vaccine Stocks.....been awhile....
The overall was a gain of 5.7% for one of the best days of 2021.
There were four double digit gainers: Immunity Bio: 15%, Gritstone: 14%, Novavax, Adaptive 11%.
There were eight gainers of over 5%: Arcturusc, Vaxart, Inovio 9%, iBio 8%, Dynavax 7%, GeoVax, EBS 6% and Alnylan 5%.
There were 23 winners and just 4 losers, but two got hit hard: Generex was down 7% and OncoSec was down 6%.
Thursday, 16 December 2021
Arcturus jumps 21% and Novavax 9%, but overall a down day
Generex slipped down another 6%, while Tonix and IMV fall around 5%. Two thirds of stocks fell.
Subscribe to:
Posts (Atom)